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Basal arterial pressure and responses to vasoconstrictors other than 
Ang II (phenylephrine, U46619, endotheline) were not modi ed in 
SM-Arhgef1-KO mice.
Our results show that Arhgef1 activation and its downstream RhoA/
Rho kinase signaling are central to the development of Ang II-
dependent hypertension. We identify Arhgef1 as an alternative 
potential target for the treatment of hypertension.
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Carotid intima media thickness (CIMT) is frequently increased in 
hypertensive patients, correlated with blood pressure levels but 
clinical trials have evaluated the effect of different antihypertensive 
drugs on CIMT with contradictory results. Because of these con icting 
results, our work aimed to address these questions by realizing a 
meta-analysis on all randomized controlled trials studying the effects 
of different antihypertensive products on the CIMT.
Methods — We systematically reviewed all randomized controlled 
trials of antihypertensive treatment on CIMT. 29 trials were 
identi ed in three databases. We conducted a combined analysis 
of antihypertensive effects using the overall effect.
Findings — A signi cant positive overall effect size on global 
comparison of CIMT with antihypertensive drugs compare to placebo 
was found using a random effect model (-0.08 [-0.13 ; -0.03]). 
Overall effect sizes were signi cant for ACE (-0.08 [-0.14 ; -0.02]) 
and beta blockers (-0.09 [-0.19 ; 0.05]) versus placebo. Data did not 
allow other comparison versus placebo. Signi cant and bene cial 
overall effect size was observed for Calcium antagonists compare 
to both ACE (0.37 [0.20 ; 0.54]) and Diuretics (-0.09 [-0.16 ; -0.02]). 
Signi cant and bene cial overall effect size was observed for AT1 
compare to Beta blockers (0.61 [0.46 ; 0.77]). In subgroup analysis, 
signi cant and bene cial overall effect size was found both for 
low and high decrease in blood pressure, for baseline CIMT lower 
or equal than 0.82 in contrast with CIMT greater than 0.82 and 
for treatment duration less than 24 months in contrast with an 
increase in CIMT after 24 months.
Interpretation — anti-hypertensive treatment is associated with a 
signi cant decrease of CIMT. Calcium channel blockers are the most 
effective treatment follow by ACE inhibitors. Standardization of the 
protocols of measurements of the CIMT is required to assess long-
term effects of CIMT reduction on cardiovascular morbi-mortality.
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La calci cation des vaisseaux sanguins est un problème clinique 
majeur puisqu’elle représente un facteur de risque de mortalité 
cardiovasculaire chez les patients diabétiques, en insuf sance 
rénale ou atteints d’athérosclérose. Il a récemment été suggéré 
que la calci cation vasculaire constituerait un phénomène actif et 
régulé, qui implique une différenciation des cellules musculaires 
lisses en cellules cartilagineuses et/ou osseuses, dont la matrice 
extracellulaire se minéralise. Notre laboratoire s’intéresse 
particulièrement à cette transformation phénotypique, et vise à 
identi er les mécanismes moléculaires sous-jacents.
A n d’évaluer les capacités de différenciation des cellules 
musculaires lisses (CML) en chondroblastes et en ostéoblastes, nous 
avons isolé des CML vasculaires à partir d’aortes de souris sauvages, 
et les avons cultivées : 1) soit sous forme de « micropellets » en 
présence de cytokines (TGF-β3, Bmp2) pour favoriser une possible 
différenciation vers la voie chondroblastique, 2) soit en monocouche 
en présence de β-glycérophosphate pour inciter un engagement 
vers la voie ostéoblastique. Le degré de différenciation a ensuite 
été déterminé, à différents temps, en procédant à un certain 
nombre de colorations histologiques spéci ques (Bleu Alcian, Bleu 
de Toluidine, Rouge Alizarin), ainsi qu’en analysant l’expression de 
gènes d’intérêt (collagènes de type 1 et 2, Sox9, Runx2, Osterix). 
De plus, notre groupe étudie l’impact de différents facteurs, tel le 
taux d’oxygénation et l’in ammation, sur l’engagement des CML vers 
une différenciation de type chondroblastique ou ostéoblastique. Ainsi 
les cultures de différenciation décrites ci-dessus ont été réalisées 
en conditions normoxiques ou hypoxiques, et en présence ou non de 
cytokines in ammatoires telles TNF-α.
A terme, notre objectif est d’utiliser les informations que nous avons 
obtenues suite à nos expériences in vitro pour mieux comprendre 
les processus d’initiation de la calci cation in vivo, notamment 
dans le modèle de la souris ApoE-/- athéroscléreuse.
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Introduction — The aim of this study was to evaluate the in uence 
of fat and lean mass on both arterial stiffness and bone mass 
density (BMD) in elderly men.
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Methods — This study was performed in 169 French males over 
60 years. Aortic stiffness was assessed by carotid/femoral pulse 
wave velocity (PWV). BMD and body composition were determined 
with a DEXA device in lumbar spine L1-L4, femoral neck and total 
body.
Results — Lean mass was positively correlated with the three 
T-scores accounting for 11.6 %, 26.6 % and 12.2 % of the variability 
in lumbar spine L1-L4, femoral neck and total body BMD T-scores 
respectively. Fat mass had no effect on BMD. However, fat mass 
was positively correlated with aortic PWV accounting for 9.8 % of its 
variability. Lean mass was not a determinant of PWV. Hypertension, 
diabetes and dyslipidemia were associated with higher PWV but 
had no effect on BMD.
Conclusions — In males from a general population over 60 years of 
age, bone and arterial aging are differently in uenced by lean and 
fat mass. Our results indicate that elderly men with high lean mass 
and low fat mass exhibit the best arterial and bone pro le, with 
the lowest arterial stiffness and the highest BMD.
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Although the viscoelasticity of large arteries has been extensively 
investigated, few studies have focused on arterial wall viscosity 
(AWV) itself and its regulation by the endothelium in vivo. This 
is of particular importance since AWV is a major source of energy 
dissipation through the vascular system reducing the ef ciency of 
cardiovascular coupling.
We simultaneously measured in 8 healthy volunteers (age: 22±1 
years) radial artery diameter and arterial pressure (NIUS02) 
before and after 8 min local infusion of L-NMMA (8 mmol/min) 
as NO-synthase inhibitor, tetraethylammonium (TEA: 9 mmol/
min), as blocker of calcium-activated potassium channels, the 
target of endothelium-derived hyperpolarizing factors (EDHF), 
and L-NMMA+TEA. Arterial pressure and diameter were carefully 
synchronized and the pressure-diameter relationship were 
constructed at each cardiac cycle. AWV was estimated from the 
ratio of the area of the hysteresis loop of the pressure-diameter 
relationship to the area representing the whole energy exchanged 
during each cardiac cycle ( gure). Radial artery stiffness was 
evaluated during the whole cardiac cycle by the calculation of 
cross-sectional distensibility and during the ventricular ejection 
period by the slope of the ascending loop.
L-NMMA did not modify signi cantly arterial distensibility and 
ascending slope but, paradoxically reduced AWV (from 29.5±0.7 to 
24.9±0.7 %, P=0.05). Conversely, TEA reduced arterial distensibility 
(from 6.50±0.19 to 5.53±0.2 10-5.kPa, P=0.002) and the ascending 
slope (from 1.03±0.01 to 0.86±0.03 mm.mmHg, P<0.001) and 
increased AWV (from 29.1±0.5 to 35.0±0.7 %, P=0.04). The 
combination of L-NMMA+TEA induced a more marked decrease 
in distensibility (from 6.86±0.24 to 4.85±0.17 10-5.kPa, P<0.001) 
and ascending slope (from 1.06±0.04 to 0.69±0.03 mm.mmHg, 
P<0.001) and increase in AWV (from 29.0±0.9 to 43.0±0.7, P=0.04) 
as compared with TEA alone (all P<0.05).
These results demonstrate in vivo in humans that the vascular 
endothelium contributes, in addition to large artery elasticity, to 
the regulation of AWV through the release of NO and EDHF.
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The old spontaneously hypertensive rat (SHR) is known to be a good 
experimental model that is highly analogous to essential hypertension 
in man but is costly and time consuming. Chronic inhibition of nitric 
oxide (NO) production in young adult SHR is an experimental model of 
malignant hypertension and chronic renal disease, very similar to old 
SHR¹. Considering that acute or chronic decreases in NO production 
in normotensive rats increase arterial stiffness, we aimed to compare 
the aortic stiffness between SHR/L-NAME and old SHR.
Male SHR (18 weeks old) received N-Nitro-L-Arginine Methyl Ester 
(L-NAME) 6 mg/kg/d in drinking water (SHR/L-NAME) for 2 weeks 
and were compared to SHR and Wistar Kyoto rats (WKY). Moreover, 
two groups are composed of 55 weeks aged SHR (Old SHR) and WKY 
(Old WKY). Under anesthesia, two catheters were introduced in the 
left common carotid artery and the left femoral artery to measure 
central and peripheral blood pressure and assess aortic stiffness 
with pulse wave velocity (PWV= distance between the tips of the 
two catheters / transit time), β-index (2.11x(PWV²/Diastolic blood 
pressure)), ampli cation and pulse pressure (PP).
At 20 weeks, although SHR have higher central systolic blood 
pressure (SBP) than WKY (201±7 mmHg vs. 154±4 mmHg), no 
signi cant difference in PWV, PP, ampli cation and β-index was 
observed between these two groups. With age, old WKY have 
higher SBP (181±8 mmHg) and higher PWV (6.7±0.5 m/s) and β-index 
(0.70±0.08) than young WKY. Old SHR exhibit higher SBP (252±13 
mmHg), PWV (9.3±0.7 m/s), PP (71±7 mmHg), β-index (1.08±0.16) 
than old WKY and young SHR (PWV=6.3±0.2 m/s, PP=39±3 mmHg 
and β-index=0.50±0.03). Young SHR, after 2 weeks of L-NAME 
administration, have higher SBP (238±10 mmHg) and aortic stiffness 
(PWV=8.6±0.6 m/s, PP=54±6 mmHg and β-index=0.89±0.14) than 
young SHR and possess the aortic stiffness observed in old SHR.
